Reactive oxygen species and superoxide dismutases: Role in joint diseases

Joint Bone Spine

Volumn 74, Issue 4, 2007, Pages 324-329

  Afonso, Valéry ^a   Champy, Romuald ^a   Mitrovic, Dragoslav ^a   Collin, Pascal ^a   Lomri, Abderrahim ^a  

^a INSERM   (France)

Author keywords

Arthritis; Crystal induced arthropathies; Reactive oxygen species; Rheumatoid arthritis; SOD mimetics; Superoxide anion; Superoxide dismutase

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE; MANGANESEDICHLORO(3,10,13,20,26 PENTAAZATETRACYCLO[20.3.1.0(4,9).0(14,19)] 1(26),22(23),24 HEXACOSATRIENE); REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TEMPOL;

ANTIOXIDANT ACTIVITY; ARTHRITIS; ARTHROPATHY; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENZYME STRUCTURE; HYPERTENSION; NONHUMAN; OSTEOARTHRITIS; OXIDATIVE STRESS; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SHORT SURVEY;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; HUMANS; MALE; NITRIC OXIDE; OSTEOARTHRITIS; OXIDATIVE STRESS; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REACTIVE OXYGEN SPECIES; RHEUMATIC DISEASES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SUPEROXIDE DISMUTASE;

EID: 34447328099     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.02.002     Document Type: Short Survey

References (50)

1. Halliwell B., Gutteridge J.M., and Cross C.E. Free radicals, antioxidants and human disease. Where are we now?. J Lab Clin Med 119 (1992) 598-620
2. Henrotin Y., Kurz B., and Aigner T. Oxygen and reactive oxygen species in cartilage degradation: friends or foes?. Osteoarthritis Cartilage 13 (2005) 643-654
3. Henrotin Y.E., Bruckner P., and Pujol J.P. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 11 (2003) 747-755
4. Sakurai H., Kohsaka H., Liu M.F., Higashiyama H., Hirata Y., Kanno K., et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 96 (1995) 2357-2363
5. Marklund S.L., Bjelle A., and Elmqvist L.G. Superoxide dismutase isoenzymes of the synovial fluid in rheumatoid arthritis and in reactive arthritides. Ann Rheum Dis 45 (1986) 847-851
6. Sandhu J.K., Robertson S., Birnboim H.C., and Goldstein R. Distribution of protein nitrotyrosine in synovial tissues of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 30 (2003) 1173-1181
7. Mathy-Hartert M., Martin G., Devel P., Deby-Dupont G., Pujol J.P., Reginster J.Y., et al. Reactive oxygen species downregulate the expression of pro-inflammatory genes by human chondrocytes. Inflamm Res 52 (2003) 111-118
8. Goebel K.M., Storck U., and Neurath F. Intrasynovial orgotein therapy in rheumatoid arthritis. Lancet 1 (1981) 1015-1017
9. Ross A.D., Banda N.K., Muggli M., and Arend W.P. Enhancement of collagen-induced arthritis in mice genetically deficient in extracellular superoxide dismutase. Arthritis Rheum 50 (2004) 3702-3711
10. Iyama S., Okamoto T., Sato T., Yamauchi N., Sato Y., Sasaki K., et al. Treatment of murine collagen-induced arthritis by ex vivo extracellular superoxide dismutase gene transfer. Arthritis Rheum 44 (2001) 2160-2167
11. Salvemini D., and Cuzzocrea S. Therapeutic potential of superoxide dismutase mimetics as therapeutic agents in critical care medicine. Crit Care Med 31 Suppl. 1 (2003) S29-S38
12. Halliwell B., and Gutteridge J.M. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186 (1990) 1-85
13. Haddad J.J. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Signal 14 (2002) 879-897
14. Wiseman H., and Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313 (1996) 17-29
15. Bruckdorfer K.R. Lipid oxidation products and vascular function. Free Radic Res 28 (1998) 573-581
16. Tiku M.L., Gupta S., and Deshmukh D.R. Aggrecan degradation in chondrocytes is mediated by reactive oxygen species and protected by antioxidants. Free Radic Res 30 (1999) 395-405
17. Davies K.J. Protein damage and degradation by oxygen radicals. I. general aspects. J Biol Chem 262 (1987) 9895-9901
18. Stadtman E.R. Oxidation of proteins by mixed-function oxidation systems: implication in protein turnover, aging and neutrophil function. Trends Biochem Sci 11 (1986) 11-12
19. Johnson F., and Giulivi C. Superoxide dismutases and their impact upon human health. Mol Aspects Med 26 (2005) 340-352
20. McCord J.M., and Edeas M.A. SOD, oxidative stress and human pathologies: a brief history and a future vision. Biomed Pharmacother 59 (2005) 139-142
21. Orr W.C., Mockett R.J., Benes J.J., and Sohal R.S. Effects of overexpression of copper-zinc and manganese superoxide dismutases, catalase, and thioredoxin reductase genes on longevity in Drosophila melanogaster. J Biol Chem 278 (2003) 26418-26422
22. Fujimura M., Morita-Fujimura Y., Noshita N., Sugawara T., Kawase M., and Chan P.H. The cytosolic antioxidant copper/zinc-superoxide dismutase prevents the early release of mitochondrial cytochrome c in ischemic brain after transient focal cerebral ischemia in mice. J Neurosci 20 (2000) 2817-2824
23. Reaume A.G., Elliott J.L., Hoffman E.K., Kowall N.W., Ferrante R.J., Siwek D.F., et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 13 (1996) 43-47
24. Huang T.T., Yasunami M., Carlson E.J., Gillespie A.M., Reaume A.G., Hoffman E.K., et al. Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts. Arch Biochem Biophys 344 (1997) 424-432
25. Okado-Matsumoto A., and Fridovich I. Amyotrophic lateral sclerosis: a proposed mechanism. Proc Natl Acad Sci U S A 99 (2002) 9010-9014
26. Afonso V., Santos G., Collin P., Khatib A.M., Mitrovic D., Lomri N., et al. TNF-α down-regulates human Cu/Zn superoxide dismutase 1 promoter via JNK/AP-1 signaling pathway. Free Radic Biol Med 41 (2006) 709-721
27. Morten K.J., Ackrell B.A., and Melov S. Mitochondrial reactive oxygen species in mice lacking superoxide dismutase 2: attenuation via antioxidant treatment. J Biol Chem 281 (2006) 3354-3359
28. Wheeler M.D., Nakagami M., Bradford B.U., Uesugi T., Mason R.P., Connor H.D., et al. Overexpression of manganese superoxide dismutase prevents alcohol-induced liver injury in the rat. J Biol Chem 276 (2001) 36664-36672
29. Kiningham K.K., Xu Y., Daosukho C., Popova B., and St Clair D.K. Nuclear factor kappaB-dependent mechanisms coordinate the synergistic effect of PMA and cytokines on the induction of superoxide dismutase 2. Biochem J 353 (2001) 147-156
30. Marklund S.L. Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci U S A 79 (1982) 7634-7638
31. Fattman C.L., Schaefer L.M., and Oury T.D. Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med 35 (2003) 236-256
32. Enghild J.J., Thogersen I.B., Oury T.D., Valnickova Z., Hojrup P., and Crapo J.D. The heparin-binding domain of extracellular superoxide dismutase is proteolytically processed intracellularly during biosynthesis. J Biol Chem 274 (1999) 14818-14822
33. Juul K., Tybjaerg-Hansen A., Marklund S., Heegaard N.H., Steffensen R., Sillesen H., et al. Genetically reduced antioxidative protection and increased ischemic heart disease risk: the Copenhagen City Heart Study. Circulation 109 (2004) 59-65
34. Martel-Pelletier J., Alaaeddine N., and Pelletier J.P. Cytokines and their role in the pathophysiology of osteoarthritis. Front Biosci 4 (1999) 694-703
35. Yudoh K., Nguyen T., Nakamura H., Hongo-Masuko K., Kato T., and Nishioka K. Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res Ther 7 (2005) 380-391
36. Loeser R.F., Carlson C.S., Del Carlo M., and Cole A. Detection of nitrotyrosine in aging and osteoarthritic cartilage: correlation of oxidative damage with the presence of interleukin-1beta and with chondrocyte resistance to insulin-like growth factor 1. Arthritis Rheum 46 (2002) 2349-2357
37. Stralin P., and Marklund S.L. Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells. Atherosclerosis 151 (2000) 433-441
38. Adachi T., Toishi T., Takashima E., and Hara H. Infliximab neutralizes the suppressive effect of TNF-alpha on expression of extracellular-superoxide dismutase in vitro. Biol Pharm Bull 29 (2006) 2095-2098
39. Terkeltaub R., Zachariae C., Santoro D., Martin J., Peveri P., and Matsushima K. Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation. Arthritis Rheum 34 (1991) 894-903
40. Liu-Bryan R., and Lioté F. Monosodium urate and calcium pyrophosphate dihydrate (CPPD) crystals, inflammation, and cellular signaling. Joint Bone Spine 72 (2005) 295-302
41. McCarty D.J., Lehr J.R., and Halverson P.B. Crystal populations in human synovial fluid. Identification of apatite, octacalcium phosphate, and tricalcium phosphate. Arthritis Rheum 26 (1983) 1220-1224
42. Prudhommeaux F., Schiltz C., Lioté F., Hina A., Champy R., Bucki B., et al. Variation in the inflammatory properties of basic calcium phosphate crystals according to crystal type. Arthritis Rheum 39 (1996) 1319-1326
43. Reuben P.M., Brogley M.A., Sun Y., and Cheung H.S. Molecular mechanism of the induction of metalloproteinases 1 and 3 in human fibroblasts by basic calcium phosphate crystals. Role of calcium-dependent protein kinase C alpha. J Biol Chem 277 (2002) 15190-15198
44. Dai L., Claxson A., Marklund S.L., Feakins R., Yousaf N., Chernajovsky Y., et al. Amelioration of antigen-induced arthritis in rats by transfer of extracellular superoxide dismutase and catalase genes. Gene Ther 10 (2003) 550-558
45. Ugur M., Yildirim K., Kiziltunc A., Erdal A., Karatay S., and Senel K. Correlation between soluble intercellular adhesion molecule 1 level and extracellular superoxide dismutase activity in rheumatoid arthritis: a possible association with disease activity. Scand J Rheumatol 33 (2004) 239-243
46. Mazieres B., Masquelier A.M., and Capron M.H. A French controlled multicenter study of intraarticular orgotein versus intraarticular corticosteroids in the treatment of knee osteoarthritis: a one-year followup. J Rheumatol Suppl 27 (1991) 134-137
47. Cuzzocrea S., Riley D.P., Caputi A.P., and Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 53 (2001) 135-159
48. Cuzzocrea S., McDonald M.C., Mota-Filipe H., Mazzon E., Costantino G., Britti D., et al. Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritis. Arthritis Rheum 43 (2000) 320-328
49. Muscoli C., Cuzzocrea S., Riley D.P., Zweier J.L., Thiemermann C., Wang Z.Q., et al. On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies. Br J Pharmacol 140 (2003) 445-460
50. Cuzzocrea S., Mazzon E., di Paola R., Genovese T., Muia C., Caputi A.P., et al. Synergistic interaction between methotrexate and a superoxide dismutase mimetic: pharmacologic and potential clinical significance. Arthritis Rheum 52 (2005) 3755-3760